Q1 2026 Holdings
Filed 2026-05-15 | 37 holdings | $272.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $59.0M | 8,474,571 | 21.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $30.3M | 787,492 | 11.1% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $19.8M | 985,100 | 7.3% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $14.5M | 380,000 | 5.3% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $14.5M | 130,000 | 5.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $11.0M | 350,000 | 4.0% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $9.0M | 125,000 | 3.3% |
| Adlai Nortye LTD(ANL) | SPONSORED ADS | 00704R109 | $8.8M | 1,265,231 | 3.2% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $8.5M | 3,631,000 | 3.1% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $7.7M | 257,500 | 2.8% |
| Scynexis Inc(SCYX) | COM NEW | 811292200 | $7.0M | 7,608,695 | 2.6% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $6.7M | 672,500 | 2.5% |
| Kalvista Pharmaceuticals Inc(KALV)Call | COM | 483497103 | $6.3M | 315,000 | 2.3% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $5.9M | 2,250,000 | 2.2% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $5.9M | 3,500,000 | 2.2% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $5.3M | 3,000,000 | 1.9% |
| Eupraxia Pharmaceuticals Inc(EPRX) | COM | 29842P105 | $4.9M | 680,000 | 1.8% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $4.6M | 325,000 | 1.7% |
| Karyopharm Therapeutics Inc(KPTI)Put | COM NEW | 48576U205 | $4.2M | 750,000 | 1.5% |
| Promis Neurosciences Inc(PMN) | COM SHS | 74346M505 | $4.1M | 324,977 | 1.5% |
| Ideaya Biosciences Inc(IDYA)Put | COM | 45166A102 | $4.0M | 120,000 | 1.5% |
| Lipocine Inc New(LPCN) | COM NEW | 53630X203 | $3.6M | 450,000 | 1.3% |
| Ideaya Biosciences Inc(IDYA)Call | COM | 45166A102 | $3.5M | 104,300 | 1.3% |
| Inventiva SA(IVA) | ADS | 46124U107 | $3.0M | 535,000 | 1.1% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $2.9M | 1,460,000 | 1.1% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $2.9M | 1,100,000 | 1.1% |
| Nextcure Inc(NXTC) | COM NEW | 65343E207 | $2.8M | 265,000 | 1.0% |
| Arrivent Biopharma Inc(AVBP)Call | COM | 04272N102 | $2.5M | 110,000 | 0.9% |
| Sol-Gel Technologies LTD(SLGL) | SHS NEW | M8694L137 | $2.5M | 31,000 | 0.9% |
| Pasithea Therapeutics Corp(KTTA) | COM NEW | 70261F202 | $1.6M | 2,100,000 | 0.6% |
| Relay Therapeutics Inc(RLAY)Call | COM | 75943R102 | $1.5M | 150,000 | 0.5% |
| Traws Pharma Inc(TRAW) | COM NEW | 68232V884 | $936.4K | 511,714 | 0.3% |
| Zentalis Pharmaceuticals Inc(ZNTL)Call | COM | 98943L107 | $936.0K | 400,000 | 0.3% |
| Therapeuticsmd Inc(TXMD) | COM NEW | 88338N206 | $849.3K | 420,421 | 0.3% |
| Spruce Biosciences Inc(SPRB) | COM NEW | 85209E208 | $797.3K | 12,200 | 0.3% |
| Werewolf Therapeutics Inc(HOWL) | COM | 95075A107 | $469.2K | 563,535 | 0.2% |
| Neuphoria Therapeutics Inc(NEUP) | COM | 64136E102 | $312.3K | 76,728 | 0.1% |